Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, HutchMED (China) LIMITED reported revenue of $549M, down 13.0% year over year. Operating margin was -7.1% and net margin 83.3%, on a free-cash-flow margin of -14.4% with capital expenditure at 2.6% of revenue. Every figure is computed directly from HCM's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $549M | -7.1% | 83.3% |
| FY2024 | $630M | -6.9% | 6.0% |
| FY2023 | $838M | 2.2% | 12.0% |
| FY2022 | $426M | -95.6% | -84.6% |
| FY2021 | $356M | -92.2% | -54.7% |
How does HCM compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AAWH · ABBV · ABCL · ABT · ABUS · ACAD
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.